D. E. Shaw & Co., Inc. Amphastar Pharmaceuticals, Inc. Put Options Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
257Shares Held
32.9MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$81.5 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$61.8 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$49.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.8 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.49B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...